Literature DB >> 1706740

The hepatitis B virus and the host response.

H C Thomas1.   

Abstract

The clearance of hepatitis B virus infected cells from the liver is probably dependent on an interplay between the interferon system and the cellular limb of the host immune response. Although the importance of the nucleocapsid proteins as targets for sensitized cytotoxic T cells is established in chronic hepatitis B infection, further studies are needed during the early phase of acute infection. The relative importance of pre-S sequences as inducers and targets of the virus neutralizing humoral immune response is becoming established but their precise place will await the development of in vitro models of hepadna virus infection and precise definition of the mechanism of viral uptake. In adult life, deficient production of alpha-interferon and suppression of the ability of the host to respond to interferon are probably important factors underlying the development of chronic infection. In the neonate, however, specific suppression of the cell-mediated immune response may be involved. The presence of a mutation in the pre-core region of some virus isolates has recently been described. Hepatocytes infected with this virus cannot produce hepatitis B e antigen and the course of the liver disease is fairly rapid. Whether this mutant causes liver damage in the same way as the wild virus or is directly cytopathic needs further study. In adult-acquired chronic hepatitis B virus infection, alpha-interferon produces hepatitis B e antigen clearance in 26-88% of cases and is followed by resolution of the hepatic inflammation. Results in neonatally acquired infection are less impressive and prednisolone priming followed by interferon may be needed.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1706740     DOI: 10.1016/0168-8278(90)90170-v

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  5 in total

1.  Extensive oxidative DNA damage in hepatocytes of transgenic mice with chronic active hepatitis destined to develop hepatocellular carcinoma.

Authors:  T M Hagen; S Huang; J Curnutte; P Fowler; V Martinez; C M Wehr; B N Ames; F V Chisari
Journal:  Proc Natl Acad Sci U S A       Date:  1994-12-20       Impact factor: 11.205

2.  Polymerase chain reaction detects hepatitis B virus DNA in paraffin-embedded liver tissue from patients sero- and histo-negative for active hepatitis B.

Authors:  I D Diamantis; C McGandy; I Pult; H Bühler; M Schmid; F Gudat; L Bianchi
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1992

3.  Antiviral effect of prolonged intermittent lymphoblastoid alpha interferon treatment in chronic hepatitis B.

Authors:  H L Janssen; L Berk; S W Schalm; R A Heijtink; G Hess; S Rossol; K H Meyer zum Buschenfelde; R A Chamuleau; P L Jansen; H W Reesink
Journal:  Gut       Date:  1992-08       Impact factor: 23.059

Review 4.  Update on Hepatitis B Virus Infection: Focus on Treatment.

Authors:  Stephanos J Hadziyannis
Journal:  J Clin Transl Hepatol       Date:  2014-12-15

5.  Distinct Cytokine Profiles Correlate with Disease Severity and Outcome in Longitudinal Studies of Acute Hepatitis B Virus and Hepatitis D Virus Infection in Chimpanzees.

Authors:  Ronald E Engle; Davide De Battista; Emily J Danoff; Hanh Nguyen; Zhaochun Chen; Paolo Lusso; Robert H Purcell; Patrizia Farci
Journal:  mBio       Date:  2020-11-17       Impact factor: 7.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.